Breast cancer is a heterogeneous disease, and there are at least five molecular subtypes associated with distinct clinical and biological behaviors: Luminal A, Luminal B, HER2-enriched (HER2+), normal-like, and Basal-like subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.